Latest stories

  • The ‘Emergency Use’ Loophole

    On Sunday, the Food and Drug Administration issued an “emergency use authorization” for blood plasma to treat COVID-19. The decision was well within the agency’s remit but nevertheless generated instant controversy. President Donald Trump had just attacked the “deep state” at the FDA for holding…